JW Holdings Corp
096760
Company Profile
Business description
JW Holdings Corp is a healthcare solutions provider. The group manufactures and sells prescription medicines, infusion solutions, injectable drugs, antibiotics, cardiovascular medicines, dermatology products, nutritional products, and other pharmaceutical products. The group generates revenue from domestic market and also via export.
Contact
38, Gwacheon-daero 7-gil
JW Building, Gyeonggi-do
Galhyeon-dong
Gwacheon-si156-010
KORT: +82 28406777
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 December 2026
Employees
134
Stocks News & Analysis
stocks
Wide moat share expects luck to turn
A tough year for jackpots however earnings are expected to normalise.
stocks
ASX share’s growth story intact despite supply constraints
Short term supply challenges but Chinese growth story remains intact.
stocks
ASX healthcare giant rallies despite a fall in profits
Easing investor concerns and signalling a return to growth.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,269.70 | 13.70 | -0.15% |
| CAC 40 | 8,476.13 | 23.04 | 0.27% |
| DAX 40 | 26,120.06 | 137.02 | 0.53% |
| Dow JONES (US) | 53,131.94 | 372.73 | 0.71% |
| FTSE 100 | 10,813.87 | 65.71 | 0.61% |
| HKSE | 26,009.46 | 310.97 | 1.21% |
| NASDAQ | 26,115.42 | 48.26 | 0.19% |
| Nikkei 225 | 66,016.36 | 200.43 | -0.30% |
| NZX 50 Index | 13,972.66 | 52.84 | 0.38% |
| S&P 500 | 7,671.51 | 30.35 | 0.40% |
| S&P/ASX 200 | 9,058.90 | 6.90 | -0.08% |
| SSE Composite Index | 3,905.20 | 1.48 | 0.04% |